Back
Aclaris Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
ACRS
Aclaris Therapeutics
Last Price:
$2.90
Seasonality Move:
31.13%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
The current trend is moderately bearish and ACRS is experiencing selling pressure, which indicates risk of future bearish movement.
Aclaris Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.11 | Sell |
| 20-day SMA: | 3.55 | Sell |
| 50-day SMA: | 2.67 | Buy |
| 200-day SMA: | 1.57 | Buy |
| 8-day EMA: | 3.1 | Sell |
| 20-day EMA: | 3.26 | Sell |
| 50-day EMA: | 2.82 | Sell |
| 200-day EMA: | 2.29 | Buy |
Aclaris Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 41.39 | Sell |
| Chaikin Money Flow: | -851829 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.02 - 4.12) | Sell |
| Bollinger Bands (100): | (0.88 - 2.98) | Buy |
Aclaris Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aclaris Therapeutics Stock
Is Aclaris Therapeutics Stock a Buy?
-
Aclaris Therapeutics share price is 2.74 while ACRS 8-day simple moving average is 3.11, which is a Sell signal.
-
The stock price of ACRS is 2.74 while Aclaris Therapeutics 20-day SMA is 3.55, which makes it a Sell.
-
Aclaris Therapeutics 50-day simple moving average is 2.67 while ACRS share price is 2.74, making it a Buy technically.
-
ACRS stock price is 2.74 and Aclaris Therapeutics 200-day simple moving average is 1.57, creating a Buy signal.
ACRS Technical Analysis vs Fundamental Analysis
Sell
19
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy or a Sell?
-
Aclaris Therapeutics stock is rated a SellThe current Aclaris Therapeutics [ACRS] share price is $2.74. The Score for ACRS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Aclaris Therapeutics Stock Info
Market Cap:
195.4M
Price in USD:
2.74
Share Volume:
1.2M
Aclaris Therapeutics 52-Week Range
52-Week High:
5.17
52-Week Low:
0.86
Sell
19
Aclaris Therapeutics (ACRS)
is a Sell
Aclaris Therapeutics Share Price Forecast
-
What is the Aclaris Therapeutics stock price today?The Aclaris Therapeutics stock price is 2.74 USD today.
-
Will ACRS stock go up or go down?Aclaris Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aclaris Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics is overvalued.
Is Aclaris Therapeutics Stock a Buy?
-
Aclaris Therapeutics share price is 2.74 while ACRS 8-day exponential moving average is 3.10, which is a Sell signal.
-
The stock price of ACRS is 2.74 while Aclaris Therapeutics 20-day EMA is 3.26, which makes it a Sell.
-
Aclaris Therapeutics 50-day exponential moving average is 2.82 while ACRS share price is 2.74, making it a Sell technically.
-
ACRS stock price is 2.74 and Aclaris Therapeutics 200-day simple moving average is 2.29, creating a Buy signal.
Fundamental Analysis of Aclaris Therapeutics
Is Aclaris Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $0.38 per share.
Technical Analysis of Aclaris Therapeutics
Should I short Aclaris Therapeutics stock?
-
ACRS Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Aclaris Therapeutics is a Buy
-
Aclaris Therapeutics Relative Strength Index (RSI) is 41.39, which suggest Aclaris Therapeutics is oversold
-
The Bollinger Bands (25) for Aclaris Therapeutics is (3.02 - 4.12), which suggest Aclaris Therapeutics is a Buy
-
The Bollinger Bands (100) for Aclaris Therapeutics is (0.88 - 2.98), which suggest Aclaris Therapeutics is a Buy
* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.